A detailed history of Conestoga Capital Advisors, LLC transactions in Danaher Corp stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 1,030 shares of DHR stock, worth $255,192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,030
Previous 1,015 1.48%
Holding current value
$255,192
Previous $253,000 13.04%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$239.25 - $280.76 $3,588 - $4,211
15 Added 1.48%
1,030 $286,000
Q2 2024

Jul 26, 2024

BUY
$235.51 - $267.98 $25,906 - $29,477
110 Added 12.15%
1,015 $253,000
Q1 2024

Apr 26, 2024

SELL
$224.58 - $256.19 $35,932 - $40,990
-160 Reduced 15.02%
905 $225,000
Q2 2023

Jul 28, 2023

BUY
$224.99 - $256.14 $6,749 - $7,684
30 Added 2.9%
1,065 $255,000
Q1 2023

Apr 21, 2023

SELL
$239.75 - $277.0 $11,987 - $13,850
-50 Reduced 4.61%
1,035 $260,000
Q4 2022

Jan 31, 2023

SELL
$241.42 - $282.29 $67,597 - $79,041
-280 Reduced 20.51%
1,085 $288,000
Q2 2022

Jul 22, 2022

SELL
$237.11 - $299.66 $5,927 - $7,491
-25 Reduced 1.8%
1,365 $346,000
Q4 2021

Jan 21, 2022

BUY
$292.08 - $329.01 $5,841 - $6,580
20 Added 1.46%
1,390 $457,000
Q2 2021

Jul 27, 2021

SELL
$225.08 - $271.69 $31,511 - $38,036
-140 Reduced 9.27%
1,370 $368,000
Q4 2020

Jan 26, 2021

SELL
$212.5 - $245.46 $39,312 - $45,410
-185 Reduced 10.91%
1,510 $335,000
Q1 2020

Apr 17, 2020

SELL
$121.39 - $169.05 $19,422 - $27,048
-160 Reduced 8.63%
1,695 $235,000
Q3 2019

Oct 25, 2019

SELL
$135.4 - $146.47 $24,372 - $26,364
-180 Reduced 8.85%
1,855 $268,000
Q2 2018

Jul 20, 2018

BUY
$96.1 - $103.24 $195,563 - $210,093
2,035 New
2,035 $201,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $180B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Conestoga Capital Advisors, LLC Portfolio

Follow Conestoga Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.